AWE
CMD

Avidian Wealth Enterprises’s Cantel Medical Corporation CMD Stock Holding History

Avidian Wealth Enterprises’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,513
Closed -$464 – 121
2017
Q4 		$464 Buy
+4,513
New +$450K 0.12% 53

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Avidian Wealth Enterprises's CMD Position: Q1 2018 in Review

Avidian Wealth Enterprises sold out of Cantel Medical Corporation (CMD) in Q1 2018, closing a stake of 4,513 shares — an estimated $464 sold.

Avidian Wealth Enterprises first reported a position in CMD in Q4 2017 and held it in 1 quarter. The position peaked at $464 in Q4 2017. 270 funds tracked by Wall St. Rank hold CMD as of Q1 2018.

  • Avidian Wealth Enterprises reported no remaining Cantel Medical Corporation position as of Q1 2018 after selling out during the quarter.
  • Avidian Wealth Enterprises sold 4,513 Cantel Medical Corporation shares in Q1 2018, an estimated $464.
  • Avidian Wealth Enterprises first reported a position in Cantel Medical Corporation in Q4 2017 and held it in 1 quarter.
  • Avidian Wealth Enterprises's Cantel Medical Corporation position peaked at $464 in Q4 2017.
  • 270 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2018.

Based on Avidian Wealth Enterprises's 13F filing for Q1 2018, filed 15 May 2018.